Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.3B | 2.1B | 2.2B | 2.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 248M | 261M | 314M | 318M |
| Other operating expenses | 187M | 835M | 194M | 281M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.0B | 18M | 1.0B | 967M |
| Tax provision | 281M | 240M | 229M | 253M |
| Net income | 763M | -895M | 817M | 715M |
| Basic EPS | 2.1 | — | 2.3 | 2.0 |
| Diluted EPS | 2.1 | — | 2.3 | 2.0 |
| Basic average shares | 328M | — | 328.4M | 328.4M |
| Diluted average shares | 328M | — | 328.4M | 328.4M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.0B | 18M | 1.0B | 967M |
| Minority interests | -58M | -30M | -59M | -54M |
| Preferred stock dividends | 28M | 27M | 29M | — |